Current Grant Opportunities

The Lymphoma Research Foundation announces Request for Proposals on a regular basis each year.  In calendar year 2019, LRF accepted applications for its 2020 Early Career Grant programs: the Clinical Investigator Career Development Award (CDA), Postdoctoral Fellowship Grant, and Lymphoma Clinical Research Mentoring Program (LCRMP).

FAQs about our grant programs are listed below. To receive an email notification when future RFPs are released, please click here to subscribe to research grant announcements.

For information about applying for patient aid grants, please visit

Active RFPs

2020 Grant Applications are now closed.  The 2021 grant cycle will open in early summer 2020. Sample RFPs from past grant programs are available at

2020 Grant Applications

Early Career Grants

Sample Policy, Terms, and Conditions

NOTE: Lymphoma Research Foundation reserves the right to establish any announcement date and deadline it deems necessary and appropriate for any RFP, and to change deadlines, forms, and guidelines, plus any and all details pertaining to grant availability, rules, eligibility criteria, selection process, etc. All LRF Research Grants are dependent on funding availability.

Research Grant FAQs

Is a Letter of Intent (LOI) required?

No a Letter of Intent (LOI) is not required.

When is the proposal due?

The submission deadline for the 2020 grant cycles is 5:00 pm EST on Thursday, September 5, 2019.

Who is eligible to apply for these grants?

Young Investigator grants are generally open to advanced fellows and junior faculty who are working at a non-profit organization or research institution such as universities, colleges, hospitals, and laboratories in the United States and Canada. The CDA and LCRMP are open to clinical fellows and faculty only; the Postdoctoral Fellowship is open to both clinical and postdoctoral fellows. Please refer to the individual RFPs for exact eligibility criteria.

Disease Focus Area grants are open to principal investigators who hold an academic faculty appointment of assistant, associate, or full professor or its equivalent, at non-profit organizations or public or private institutions such as universities, colleges, hospitals, and laboratories in the United States and Canada, as long as the project fits the focus area criteria outlined in the RFP. For-profit entities are not eligible to apply for LRF funds.

Please refer to the most recent RFP for current eligibility criteria for each program.

If you are unsure if you or your project is eligible for a particular grant project, please contact well in advance of the deadline.

What are the citizenship requirements for applicants?

Eligible applicants must be a citizen of the United States or Canada or hold a visa to work in the United States or Canada. In addition, applicants must be able to commit to remaining at an American or Canadian institution for the duration of the project. *In some cases, Disease Focus Area grants may allow international collaborators if the majority of work is being done at a U.S. or Canadian institution. 

Are American/Canadian citizens working at an institution in another country eligible?

No. Applicants to these programs must be based at an institution in the United States or Canada for the duration of the project.

Are proposals with multiple Principal Investigators (PIs) acceptable?

Applications should be filed in the name of one person who will serve as the primary PI for administrative purposes (disbursing funds, filing reports, etc.).

For Disease Focus Area grants, a “co-PI” may be designated in the Key Personnel section if appropriate to a collaborator’s role in the project. Young Investigator Grants should not include co-PIs.

Must a hard copy of the entire application be mailed?

No. Applicants are not required to mail a hard copy of any application component. Please note that the signature and waiver pages must be printed, signed by the appropriate institutional officials, and uploaded into the application as a PDF before submission.

What font should I use?

Any legible font 11 points or larger is acceptable.

Are there limits on the number of pages?

Yes, please refer to the RFP for each program for page limits.  Please note that where page limits are indicated, proposals which exceed those limits will be disqualified from review.

Is there a required format for my letters of support?

The format of letters of support is left to the discretion of the writer; please refer to each program’s RFP for content requirements. All letters should be submitted on institutional letterhead.

Postdoctoral Fellowship, CDA, and LCRMP applicants should note that their mentor or sponsor letter should include a detailed description of the applicant’s contribution to the proposed project (any work you, as the applicant, did to develop the project independently of your sponsor or other colleagues).

Please note that additional letters, uploaded as part of the appendix, may be required to verify support from pharmaceutical partners or other collaborating entities. Review each program’s RFP for details.

Is there any specific format for publications?

Publications must be uploaded in PDF format.

How should I upload my assurances (i.e. IRB, IACUC, biohazards)? What if I don’t have approval yet?

If IRB/IACUC/etc. approval is applicable to the project and has been received, select “approved,” fill in the appropriate certificate numbers, and upload proof of approval as an attachment. Note: applicants only need to upload proof of approval, not the full assurance.

If approval has not yet been received, select “pending” as the response, and do not upload an attachment.  Please note that you must demonstrate receipt of the appropriate assurances in order to receive your award, if selected. You will be asked to provide proof of approval after you are notified of your award.

LCRMP applicants will also be asked to indicate any pending or procured assurances on the Cover Sheet template.

Why is proposalCENTRAL asking me to import my Other Research Support from my profile? Do I have to import this info or can I fill it in manually?

proposalCENTRAL allows applicants to store other research support in their individual profile and import it into an application as needed. Follow the directions on the application page to import funding from your profile to the application, or use the indicated buttons to open your profile to add new entries.  For technical assistance with this section, contact proposalCENTRAL technical support at .

Who conducts the grant review?

Applications will be reviewed by members of LRF’s Scientific Advisory Board (SAB), which is comprised of some of the leaders in the field of lymphoma research, and, where applicable, other researchers with expertise in the specific areas being funded.

Will I have the opportunity to respond to feedback and re-submit my application?

The LRF Scientific Advisory Board may elect to provide feedback to applicants discussed during the final round of review. This feedback will be for the improvement of future grant submissions only; responses and resubmissions during the current grant cycle are not permitted. The SAB’s decision is final.

When will I find out if I have been selected for an award?

Applicants will be informed in writing by no later than December 20, 2019.

What biosketch format should my key personnel and I use?

Please use the current NIH  biosketch format. Postdoctoral Fellowship applicants should note that if they choose to use the fellowship biosketch they are not required to include grades and courses in Section D. All other grant applicants and any mentors, sponsors, or key personnel should use the non-fellowship biosketch template.

I am an early-career grant applicant, can I have a mentor/sponsor who is not at my home institution?

Your primary mentor/sponsor should be based at your home institution, however, you are welcome to have associate mentors or sponsors at other institutions if their expertise will be particularly relevant to your proposed project.  Please note if you have more than one mentor/sponsor, a biosketch should be submitted for each person, and each person should submit separate recommendation letters – however the associate mentor/sponsor letters may count towards your additional required recommendation letters.

Must my CDA project involve clinical research?

Yes– the focus of the training is to prepare clinicians to design and administer clinical studies in lymphoma and to take on the primary responsibilities for clinical trial design, protocol writing, Institutional Review Board (IRB) submission, and publication. Proposals must involve clinical observation of human subjects and may include study or development of new diagnostic, methods, therapies, and/or outcome measurements directed to patients with lymphoma. Studies or proposals that are exclusively laboratory based are not appropriate for this program.

Are non-clinicians eligible to apply for the CDA?

No– applicants must be licensed clinical physicians in one of the ACGME accredited specialties and be working at a clinical research institution in the United States or Canada for the duration of the grant award period.

What time commitment is required for the CDA?

The Clinical Investigator must spend a minimum of 35 to 50 percent of his/her time in research. This time should be free of major patient care, teaching or administrative responsibilities.

Must my Fellowship project involve clinical research?

No, both laboratory and clinic based projects are acceptable, but the results and conclusions must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/or non-Hodgkin lymphoma. Areas of research may include, but are not limited to, etiology, immunology, genetics, therapies and transplantation. Historically, successful applications in this program have focused on basic, translational, and epidemiological research.

I’m not a faculty member yet, but I will be starting a position this fall. Can I apply for a Fellowship grant?

No– Postdoctoral Fellowships are not open to applicants in faculty positions prior to the start of the award period (March 1, 2020).  Applicants receiving an award may move into a faculty position during the period of the grant.  Junior faculty members in clinical research may be eligible to apply to the CDA or LCRMP programs; see those RFPs for details.

I have a PhD, and I’m doing postdoctoral work, not an ACGME fellowship program – what does the “two years” requirement mean for me?

If you are a PhD not participating in an ACGME fellowship program, the two year requirement does not apply to you. You may apply for the fellowship at any time in the first five years (60 months) of your postdoctoral work, as long as you will not be beyond five years as of March 1, 2020.

I have an MD and I’m a clinical fellow – do I have to meet both the two year minimum and five year maximum requirement?

Yes– clinical fellows must have completed at least two years (24 months) of fellowship work and no more than five years (60 months) of fellowship work as of March 1, 2020 to apply for a Postdoctoral Fellowship.  If you are beyond the five year limit, you may be eligible for either the CDA or LCRMP programs – see those RFPs for details.

What time commitment is required for a Fellowship?

The Fellow must spend a minimum of 80 percent of his/her time in research without major patient care, teaching, or administrative responsibilities except as such responsibilities relate directly to a pre-clinical or clinical lymphoma research project.

How are the LCRMP eligibility requirements calculated?

By the LCRMP workshop in March 2020, applicants must be considered at least a second-year fellow or not have gone beyond 4 years in their first faculty position. Applicants must also not have exceeded four years past completion of their clinical fellowship or twelve years past completion of their MD by March 2020.

What time commitment is required for the LCRMP?

Selected applicants must be able to attend and participate in all parts of the program including the workshop from March 3 through March 7, 2020, in Scottsdale, AZ, the follow-up meetings in Fall 2020 and 2021, and LRF required communication, reporting, and evaluation.

Is my Mentor required to attend the workshop?

No, Mentors are expected to provide support and guidance to the Applicant while he/she is at their home institution and assist with the execution of the Applicant’s research project. They will not be asked to attend the March workshop or follow up programs.

I am a fellow anticipating moving into a faculty position in 2020. How do I address this in my application?

Please see the cover sheet and instructions for the Research Proposal in the RFP, which note where you should address any anticipated changes of rank or institution, and its estimated impact on your research proposal.

Are non-clinicians eligible to apply to the LCRMP?

No. Applicants must demonstrate a clear interest and commitment to a career in lymphoma clinical research, and be either in at least their third year or have completed one of the following ACGME accredited sub-specialty fellowship programs: Hematology/Oncology, Hematology, Medical Oncology, Radiation Oncology, Pediatric Hematology/Oncology, or Hematopathology.

Must my LCRMP project involve clinical research?

Yes. The focus of the LCRMP is to assist in the development of a specific clinical trial in patients with lymphoma and to set the foundation for grant development to support the trial. Proposals must involve clinical observation of human subjects and may include study or development of new diagnostic, methods, therapies, and/or outcome measurements directed to patients with lymphoma. Studies or proposals that are exclusively laboratory based are not appropriate for this program.

I’ve already participated in a different mentorship program with ASH (or any other organization). May I apply for the LRF program?

Yes. Applicants who have completed ASH’s CRTI program or another mentorship program may apply for LRF’s program. However, you may not participate in another competitively applied for mentorship during the period of the LRF program (March 2020 through October 2022).